Viewing Study NCT06255392


Ignite Creation Date: 2025-12-24 @ 3:45 PM
Ignite Modification Date: 2025-12-27 @ 1:15 PM
Study NCT ID: NCT06255392
Status: RECRUITING
Last Update Posted: 2025-08-15
First Post: 2024-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module